Literature DB >> 8430647

On the value of the activated clotting time for monitoring heparin therapy in acute coronary syndromes.

G Melandri1, A Branzi, A M Traini, F Semprini, V Cervi, B Magnani.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8430647     DOI： 10.1016/0002-9149(93)90461-k

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN： 0002-9149            Impact factor:   2.778


× No keyword cloud information.
  4 in total

1.  Bedside coagulometry during intravenous heparin therapy after coronary angioplasty.

Authors:  A P Schroeder; L L Knudsen; S E Husted; L Knudsen; J Ingerslev
Journal:  J Thromb Thrombolysis       Date:  2001-10       Impact factor: 2.300

2.  Safety and efficacy of fixed-dose heparin in carotid endarterectomy.

Authors:  A Poisik; E J Heyer; R A Solomon; D O Quest; D C Adams; C M Baldasserini; D J McMahon; J Huang; L J Kim; T F Choudhri; E S Connolly
Journal:  Neurosurgery       Date:  1999-09       Impact factor: 4.654

3.  The use of the activated clotting time for monitoring heparin therapy in critically ill patients.

Authors:  Jan J De Waele; Sebastiaan Van Cauwenberghe; Eric Hoste; Dominique Benoit; Francis Colardyn
Journal:  Intensive Care Med       Date:  2003-01-16       Impact factor: 17.440

4.  Early reactivation of ischaemia after abrupt discontinuation of heparin in acute myocardial infarction.

Authors:  G Di Tano; A Mazzù
Journal:  Br Heart J       Date:  1995-08
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.